Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex.
about
The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infectionsCommon duckweed (Lemna minor) is a versatile high-throughput infection model for the Burkholderia cepacia complex and other pathogenic bacteriaGalleria mellonella as a model system for studying Listeria pathogenesis.Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex.Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia-specific bacteriophages.Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.Genomic characterization of JG068, a novel virulent podovirus active against Burkholderia cenocepacia.Genomes and characterization of phages Bcep22 and BcepIL02, founders of a novel phage type in Burkholderia cenocepaciaThe isolation and characterization of two Stenotrophomonas maltophilia bacteriophages capable of cross-taxonomic order infectivity.Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cellsDissecting novel virulent determinants in the Burkholderia cepacia complex.The isolation and characterization of Stenotrophomonas maltophilia T4-like bacteriophage DLP6.Effect of nutrient deprivation on the susceptibility of Galleria mellonella larvae to infection.Identification and characterization of ϕH111-1: A novel myovirus with broad activity against clinical isolates of Burkholderia cenocepacia.Impacts of Antibiotic and Bacteriophage Treatments on the Gut-Symbiont-Associated Blissus insularis (Hemiptera: Blissidae).Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing.The temperate Burkholderia phage AP3 of the Peduovirinae shows efficient antimicrobial activity against B. cenocepacia of the IIIA lineage.'Get in Early'; Biofilm and Wax Moth (Galleria mellonella) Models Reveal New Insights into the Therapeutic Potential of Clostridium difficile Bacteriophages.Mathematical modelling of CRISPR-Cas system effects on biofilm formation.Characterization of DC1, a broad-host-range Bcep22-like podovirusPhage Therapy is Effective in Protecting Honeybee Larvae from American Foulbrood Disease.Efficiency of bacteriophage therapy against Cronobacter sakazakii in Galleria mellonella (greater wax moth) larvae.Inactivation of Burkholderia cepacia complex phage KS9 gp41 identifies the phage repressor and generates lytic virions.Cangene gold medal award lecture - Genomic analysis and modification of Burkholderia cepacia complex bacteriophages.Generous hosts: Why the larvae of greater wax moth, Galleria mellonella is a perfect infectious host model?Identification and Characterization of Type IV Pili as the Cellular Receptor of Broad Host Range Stenotrophomonas maltophilia Bacteriophages DLP1 and DLP2.Standardization of Larvae to Provide Reliable and Reproducible Results in the Study of Fungal Pathogens
P2860
Q21131311-8AC39AFD-E3AB-4ACA-8705-E5D0116A89FCQ28534865-5E56EFD5-D070-4648-8F42-52BCFDF3EEF9Q33559500-9743D183-7D34-4655-8303-4C025C2061D6Q33727287-C678B671-DE40-401E-BE3F-D24192AE6AEEQ33798541-58511CA2-7309-47E4-9993-EB273224AC3AQ34296269-7B828D69-75E7-4A11-93C6-630BE3641F45Q34933915-26D321B9-4620-499B-981E-128A46F836E6Q34974472-50B23FAD-22F0-451B-A353-EBDF096F27DCQ35274632-95BAE4C6-9FD0-4005-918B-037A40E796F7Q35763512-866BA8FE-00CA-4048-A6D5-B2D65A1E5175Q35827006-75C28DC8-D483-4C25-B0EF-586FA99B3CDCQ36235377-9F7D7B5B-3CD0-4959-84FF-CAC79AE1019BQ36307585-5904AABB-36B2-4753-AE88-4A78557A15D7Q36472126-0C1D7336-9790-4C54-AAD9-4C15CF377F07Q37313625-B220E980-8200-4C29-A7F9-63C07C35C6DAQ37542744-E4C37882-3624-4B4B-9595-B0358FD08048Q38686917-7AD6A410-F010-4E8D-8089-019723D72496Q39259998-A67BE48F-7960-40C8-A513-E161CE50A8EAQ39388122-6284DB92-DBB1-4C89-ABCA-DC97965F8E2DQ40244123-12B124D9-2CB9-4ECA-BCF6-1B25C9686815Q40598053-4AFEAE56-EB14-4B4E-A283-01923A0BD0F2Q41127154-0730474E-0CA0-4429-ABF8-2C62082F7DBCQ42004072-328ADF35-9307-47B2-85FE-65E06EEDDF29Q42216737-0B504126-62D1-4088-8689-A994EF9A8AD9Q48293875-F314A3A2-54E8-4774-811D-E79E32FB40EBQ54221224-402074B9-3306-4786-B06E-441A558D5E0EQ55710360-28312D24-7971-4B24-B586-F5DCEBAAFCA3Q58761035-E6BD37C8-EE4E-42AA-A8F2-DFD0FE0DE287
P2860
Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Experimental bacteriophage the ...... Burkholderia cepacia complex.
@en
Experimental bacteriophage the ...... Burkholderia cepacia complex.
@nl
type
label
Experimental bacteriophage the ...... Burkholderia cepacia complex.
@en
Experimental bacteriophage the ...... Burkholderia cepacia complex.
@nl
prefLabel
Experimental bacteriophage the ...... Burkholderia cepacia complex.
@en
Experimental bacteriophage the ...... Burkholderia cepacia complex.
@nl
P2860
P356
P1476
Experimental bacteriophage the ...... e Burkholderia cepacia complex
@en
P2093
Kimberley D Seed
P2860
P304
P356
10.1128/AAC.01166-08
P407
P577
2009-02-17T00:00:00Z